STAAR Surgical公司(纳斯达克代码:STAA)今日盘前股价狂泻37.39%,引发投资者关注。这一令人震惊的暴跌,主要源于该公司发布的2024年第四季度财报利空。
根据财报数据,STAAR Surgical在2024年第四季度录得每股亏损0.69美元,远高于分析师预期的每股亏损0.16美元,同比下滑531.25%。季度销售额同比下滑100%,至4895万美元,远低于7728.5万美元的预期值。
STAAR Surgical的不佳业绩表现,引发了市场对该公司核心业务增长潜力的严重质疑。面对当前的巨大挑战,公司高层及时向投资人传达坦诚信息,表露出积极应对的决心。市场等待公司下一步行动计划,并希望STAAR Surgical能尽快走出低谷,重新站稳脚跟。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.